Richard Zuckerman, MD, MPH, Associate Professor of Medicine, came to Dartmouth in 2005 after completing his fellowship at the University of Washington in Seattle. He is the Director of the Transplant Infectious Disease Program at Dartmouth, a service that he has developed since his arrival. He has established an active inpatient and outpatient service for infectious disease care of immunocompromised hosts from the hematology and solid organ transplant services. He is involved in teaching and research in both stem cell transplantation and in solid organ transplantation. He has done research evaluating pre-autologous stem cell transplant predictors of immune response to pneumococcal vaccination. In an extension of his fellowship research, Dr. Zuckerman is also involved in international clinical trials of the interactions between HSV and HIV infections. He is also involved in the evaluation of immunologic reconstitution after solid organ transplantation, including evaluating biomarkers to predict optimal immune suppression regimens. Dr. Zuckerman is involved in teaching medical students and actively mentoring multiple fellows and residents in research projects, and is currently director of the ID fellowship program at Dartmouth-Hitchcock Medical Center (DHMC).
Dr. Bryan Marsh received his MD from the University of Chicago, and then completed his training with residency and fellowship at Dartmouth-Hitchcock Medical Center. He joined the faculty of the Section of IDIH in 1996 and is now an Associate Professor of Medicine. Dr. Marsh's main interest is in the care of people living with HIV/AIDS, but his clinical activities also include consultation in general infectious diseases as well as on the transplant consultation service. He is the Medical Director of the HIV Program and the Ryan White Part C Program, the Director of the Comprehensive Antimicrobial Program, and since January 2007 the Acting and then permanent Chief of the Section of IDIH.
Dr. Lisa Adams is the Associate Dean for Global Health, Director of Global Initiatives, and an Associate Professor of Medicine in the Section of Infectious Disease and International Health at Dartmouth’s Geisel School of Medicine. She oversees Dartmouth College’s Global Health Initiative at the John Sloan Dickey Center for International Understanding and is the Director of Geisel’s Center for Health Equity. In all her roles, she develops and oversees cross-cutting global health programs and partnerships involving faculty, staff, and students.
She has worked in domestic and international TB care and prevention for over 25 years. As an international TB consultant, she has worked in over a dozen countries to provide technical assistance to Ministries of Health. She has published extensively on her TB and HIV research and on global health equity and education. At Dartmouth, she teaches global health and health equity to medical and college students. She is engaged in research on TB and HIV care and leading a major training initiative through the DarDar Programs, a collaboration between Dartmouth and Muhimbili University in Dar es Salaam, Tanzania. In 2012, she spent six months in Rwanda as Dartmouth’s lead to launch the major medical education initiative, the Rwandan Human Resources for Health Program. She recently worked with host partners in China, Eswatini (formerly Swaziland), South Africa, and Ukraine on projects to improve the delivery of TB care services to vulnerable populations, including HIV-infected individuals, children, and those suffering from drug-resistant TB.
Antonia Altomare, DO, MPH, is an Infectious Disease physician at Dartmouth-Hitchcock Medical Center (DHMC) and Assistant Professor of Medicine at Geisel School of Medicine at Dartmouth. Dr. Altomare is the Hospital Epidemiologist as well as the Program Director for the Ryan White Part D HIV Program at DHMC. She completed her medical school training at the New York College of Osteopathic Medicine and residencies in Internal Medicine and Preventive Medicine, as well as a fellowship in Infectious Diseases at DHMC. Additionally, she has a Masters of Public Health from the Dartmouth Institute for Health Policy & Clinical Practice. Her primary interests are quality improvement within infection control and HIV care, and she treats everything from general infectious diseases to immunocompromised hosts, with an interest in HIV.
Dr. Michael Calderwood was named Chief Quality Officer of DHMC in February 2021. He had served as Associate Chief Quality Officer for D-H since 2019. As Chief Quality Officer for DHMC, his responsibilities include management and oversight of the integration of safety, quality, patient experience and value/process improvement activities, along with oversight of quality assurance and regulatory compliance. In addition, he works closely with other D-H chief officers to identify organizational quality, safety, patient experience and value opportunities annually and develop policies, programs, metrics, reporting and accountability to aggressively implement improvement.
Dr. Calderwood earned a bachelor's degree in Biology from Harvard followed by a medical degree from the University of Chicago Pritzker School of Medicine. He completed his residency in Internal Medicine at Brigham and Women's Hospital and a fellowship in Infectious Diseases in the combined Brigham and Women's Hospital/Massachusetts General Hospital program in Boston. He also holds a master's of public health degree from the Harvard School of Public Health.
He started his career on staff at Brigham and Women's Hospital where he directed the hospital's antimicrobial stewardship program, was one of the hospital epidemiologists, and was a research investigator in the Therapeutic Research and Infectious Disease Epidemiology group in the Harvard Medical School Department of Population Medicine. This research involved collaborations with the Centers for Disease Control and Prevention, the Centers for Medicare & Medicaid Services, and the Agency for Healthcare Research and Quality.
Dr. Calderwood joined Dartmouth-Hitchcock in 2016, and is an Associate Professor of Medicine at the Geisel School of Medicine at Dartmouth. He is an active physician in the Section of Infectious Disease and International Health, and is board certified in Internal Medicine and Infectious Disease. Prior to his current leadership role, he served as Regional Hospital Epidemiologist for the Dartmouth-Hitchcock Health system, as the Medical Co-director of the Collaborative Healthcare-associated Infection Prevention (CHIP) team, and as one of the leaders of the DHMC Comprehensive Antimicrobial Program. He continues to serve as Co-chair the D-H Quality Committee, SEARCHES (Significant Event Analysis of Root Causes and Hospital Systems) and the System Pharmacy & Therapeutics Committee.
Dr. Calderwood was elected a fellow of the Infectious Diseases Society of America, is a member of the Society for Healthcare Epidemiology of America, and has served on a number of committees and workgroups in both organizations. He is also active in a number of state advisory workgroups and has been actively engaged in the D-HH system response to the COVID-19 pandemic.
David De Gijsel, MD, MSc, MPH, works on the intersection of poverty and health. Currently, he focuses on the infectious complications of injection drug use, specifically on new care models for the integrated treatment of hepatitis C in people who inject drugs. He has been involved in global health education and service delivery in various African countries.
David hails from the Netherlands, where he completed medical school at the University of Amsterdam. He completed his residency in Internal Medicine and Primary Care at Montefiore Medical Center/Albert Einstein College of Medicine in the Bronx, NY. He stayed at Montefiore as an internist for several years before spending two years in Kigali, Rwanda, teaching Rwandan medical students and residents through the Human Resources for Health Program. Upon his return to the U.S., he came to Dartmouth-Hitchcock for a fellowship in Infectious Disease and a residency in Leadership Preventive Medicine. He holds appointments as Assistant Professor at the Geisel School of Medicine and at The Dartmouth Institute for Health Policy & Clinical Practice.
Dr. Colleen Kershaw received her MD from Georgetown University School of Medicine, and went on to complete Internal Medicine residency as well as Infectious Disease fellowship at Beth Israel Deaconess Medical Center in Boston, where her academic focus centered on medical education. She also completed a fellowship in Global Health through the Botswana-Harvard Partnership with Beth Israel Deaconess and Scottish Livingstone Hospital in Botswana. Her clinical interests are broad in general infectious disease but in particular include care of underserved and marginalized populations, with a focus on the intersection of infectious disease and addiction. She has training and interest in medical education as well as quality improvement work, and currently serves as the Medical Director for the Outpatient Parenteral Antimicrobial Program as well as Assistant Hospital Epidemiologist, with a focus on surgical site infections.
Dr. Samuel Lee, MD, PhD, Professor and Vice Chair for VA Affairs, received his MD from the Boston University Seven-Year Liberal Arts/Medical Education Program and went on to complete his internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania, and his Infectious Diseases Fellowship training at Yale-New Haven Hospital. He also completed a Ph.D in Investigative Medicine at Yale Graduate School. He obtained a VA Career Development Award studying molecular fungal pathogenesis, and began a research laboratory at the University of Texas Health Science Center at San Antonio and the Audie L. Murphy VA Medical Center. He later became Section Chief of Infectious Diseases and Medical Director of the HIV Primary Care Clinic at the Raymond G. Murphy VA Medical Center in Albuquerque, and Associate Professor and Professor of Medicine with tenure at the University of New Mexico School of Medicine. Most recently, he has taken on the role of Chief of Medicine at the White River Junction VA Medical Center. His research, which is funded by the VA and NIH, is focused on the molecular pathogenesis of invasive candidiasis and antifungal drug discovery. His clinical interests include diagnosis and management of invasive fungal infections, and antimicrobial stewardship.
Dr. Paul Palumbo obtained his MD at the University of Vermont, followed by residency training at the Medical College of Virginia and Dartmouth-Hitchcock Medical Center and fellowship in pediatric ID at Stanford University. He joined the faculty of Cornell-Weill Medical College followed by UMD-New Jersey Medical School, and joined the Dartmouth faculty as Professor of Medicine and Pediatrics in 2006. Dr. Palumbo's research interests include many aspects of pediatric HIV. He currently is the Vice Chair of the International Maternal, Pediatric, Adolescent AIDS Clinical Trials Network (IMPAACT), and the director of the DARDAR Pediatric Program. At Dartmouth he is the primary pediatric HIV physician, but his clinical activities also include general pediatric ID.
Dr. Jeffrey Parsonnet obtained his MD from NYU School of Medicine. He then did his Medicine residency at Yale-New Haven Hospital and an ID fellowship in the Brigham and Women's/Beth Israel Hospital Combined Program. He came to Dartmouth in 1990, where he is now Professor of Medicine. Dr. Parsonnet is a nationally recognized authority on the epidemiology, pathogenesis, and treatment of toxic shock syndrome (TSS), which he has been studying for the past three decades. Dr. Parsonnet has also been the institutional PI for multiple sponsored clinical studies, mainly dealing with new treatments for staphylococcal infections and septic shock. In addition to his ongoing research, Dr. Parsonnet is an active clinician, in both general ID and HIV medicine, and has spearheaded DHMC's HIV outreach program in Brattleboro, VT. He has a special interest in staphylococcal infections and Lyme disease. Dr. Parsonnet directed the ID fellowship program at DHMC from its inception until 2010.
Dr. Surachai Supattapone's education includes obtaining a D.Phil. in Physiology from Oxford University as a Rhodes Scholar, followed by an MD and PhD in neuroscience at Johns Hopkins University School of Medicine, where his thesis project identified the inositol trisphosphate (IP3) receptor under the mentorship of Solomon H. Snyder. Dr. Supattapone subsequently completed his residency in Internal Medicine at Massachusetts General Hospital, fellowship in Infectious Diseases at UCSF, and then a post-doctoral fellowship also at UCSF working under the mentorship of Stanley B. Prusiner. In 1998, Dr. Supattapone received both the Burroughs Wellcome Career Development Award and the National Institutes of Health (NIH) physician-scientist (K08) award. He joined the faculty of Dartmouth Medical School in 2001, where he is currently Professor of Biochemistry and of Medicine, and where he and his colleagues are studying the pathogenesis of prion diseases using novel biochemical and genetic model systems.
Dr. Elizabeth Talbot received her MD from Robert Wood Johnson Medical School, University of Medicine and Dentistry of NJ, followed by residency and ID and Global Health fellowship at Duke University Medical Center. She subsequently was with the CDC for five years, first in the Epidemic Intelligence Service and then as the Team Leader for TB/HIV, International Activities, Div. of TB Elimination) and internationally as the Associate Director for TB/HIV Research in Botswana. She was seconded to the WHO for policy development for the Global Fund Against AIDS, Tuberculosis and Malaria, and then came to D-H in 2003. Dr. Talbot is currently an Associate Professor of Medicine, and has served as the Deputy State Epidemiologist (DSE) for the State of New Hampshire DHHS. Since July 2007, Dr. Talbot became a consultant for the Foundation for Innovative New Diagnostics (FIND) in Geneva. Her work at DHMC includes consultation on general infectious diseases with a focus on mycobacterial and tropical infections, as medical director of the Global Health and Travel Clinic. She has extensive international experience in tuberculosis, including work with PEPFAR in Haiti, PATH in Democratic Republic of Congo, Fogarty in Tanzania, and USAID in eSwatini. She has been on the Scientific Committee for the NIH research network, IMPAACT, representing pediatric TB research. Her research activities are primarily on tuberculosis (focused on diagnostics), but she continues to engage in outbreak and epidemiologic investigations both domestically and internationally such as coordinating training for healthcare workers responding to the West Africa Ebola epidemic. Examples of ongoing research include operations research of isoniazid preventive therapy in eSwatini; improving latent tuberculosis infection diagnosis; and point of care active TB testing among people living with HIV.
Dr. Thomas Taylor received his MD at the University of Colorado, followed by internship and residency at the Beth Israel Hospital, Rheumatology fellowship at the Robert B. Brigham Hospital and Infectious Disease fellowship at the New England Deaconess Hospital. He has been on the faculty of Dartmouth Medical School, with a primary clinical appointment at the White River Junction VA (where he is Chief of both the Rheumatology and Infectious Disease Sections) and a secondary appointment at DHMC. He is currently Associate Professor of Medicine, with appointments in both Infectious Diseases and Rheumatology and continues an active practice in both.
Dr. Ford von Reyn is Professor of Medicine and the Director of the DARDAR International Programs at Dartmouth Medical School. He received his MD from Harvard Medical School, followed by residency and Infectious Disease fellowship at Beth Israel Hospital in Boston and training with the Epidemic Intelligence Service at the Centers for Disease Control. Dr. von Reyn joined the faculty of DMS in 1988 as the Chief of the Section of Infectious Disease and remained in that position until 2007 when he stepped down to focus his work on the DARDAR International Programs and other research activities.
Dr. von Reyn is responsible, among other accomplishments, for the growth of the IDIH Section to its current size, the development of the DH HIV Program, the introduction of antimicrobial management and infection control programs at DH, and the growth of international activities at DMS. In addition, he maintained a very active clinical practice through 2007. He was the acting Chair of the Department of Medicine at DH from 1998-1999 and has been a member or chair of many regional, national and international committees.
Dr. von Reyn's research interests focus primarily on mycobacterial infections and most recently on tuberculosis, with a particular focus on novel vaccines and pertinent immunology. He has built the international collaboration resulting in the many activities of the DARDAR Programs, and remains the Director of these programs.
Dr. Peter Wright received his MD from Harvard Medical School, followed by training at NIAID and then residency and fellowship at Children's Hospital in Boston. He subsequently had an extensive research career at Vanderbilt (where he was Professor of Pediatrics, Professor of Microbiology and Immunology, Professor of Pathology, and Chief, Division of Pediatric Infectious Disease), and came to Dartmouth part-time (split with Vanderbilt) in July, 2007. In July 2008, he transitioned to full-time at Dartmouth. Dr. Wright's research interests have revolved around viral pathogenesis and vaccine development. In addition, he has provided leadership for a large HIV treatment clinic in Haiti that has become a model of success for antiretroviral therapy in a resource limited setting.
At Dartmouth he heads the development of a Clinical Translational Research Core and has support for the evaluation of novel influenza vaccines. His primary clinical interest in is Pediatric Infectious Disease.